Patients who received chemotherapy after bladder cancer surgery demonstrated an approximately 30 percent lower risk of death than those patients who underwent surgery alone, revealed an analysis by researchers at the Icahn School of Medicine at Mount Sinai and the Lahey Clinic in Burlington, MA.
Researchers used a large database of patients diagnosed with cancer in the United States. They analyzed 5,653 patients, of which 1,293 patients received adjuvant chemotherapy versus 4,360 patients who received surgery alone. They found that patients receiving adjuvant chemotherapy after surgical treatment had improved overall survival when compared to patients who received surgical treatment alone with only post-surgical observation.
Bladder Cancer
Bladder Cancer affects the urinary bladder and can be superficial or deep type and this affects its recurrence rate & prognosis.
Advertisement
Lead researcher Dr. Galsky said, "Until now, data supporting adjuvant chemotherapy has been mixed. Our analysis of actual cases supports the use of chemotherapy after surgery for patients with locally advanced bladder cancer. Chemotherapy prior to surgery remains the optimal approach for patients with bladder cancer based on the available evidence. However, population-based observational studies may be used to help fill the knowledge void in situations where clinical trials have not yielded definitive evidence. This comparative effectiveness analysis may help inform the care of patients with bladder cancer who have not received chemotherapy prior to surgery."
The study will be presented at the 2015 Genitourinary Cancers Symposium.
Source: Medindia
Source: Medindia
Novel Mechanism may Explain Chemo-Resistance in Bladder Cancer
A novel mechanism, similar to how normal tissue stem cells respond to wounding, may explain why bladder cancer stem cells contribute to chemo-resistance after multiple cycles of chemotherapy drug treatment.
Advertisement
 Bladder Cancer Risk, Recurrence, Progression and Patient Survival Linked To Genetic AlterationsGenetic alterations in a particular cellular pathway are linked with bladder cancer risk, recurrence, disease progression, and patient survival finds a new analysis. | Advertisement
|
Research Shows Hope for Bladder Cancer Patients
An estimated 10,000 people are diagnosed with bladder cancer each year in the UK. It is the seventh most common cancer in the UK, affecting men more than women.
Advertisement
Recommended Readings
Latest Cancer News
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
